Sophie Jacqueminet

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

Vlad Ratziu, Philippe Giral, Sophie Jacqueminet et al. · Gastroenterology · 2008 · 618 citations · Full text

Hepatology, Nonalcoholic Fatty Liver Disease, Medicine +10

Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012

Cécile Billionnet, Delphine Mitanchez, Alain Weill et al. · Diabetologia · 2017 · 587 citations · Full text

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnès Hartemann, G. Bensimon, Christine Payan et al. · The Lancet Diabetes & Endocrinology · 2013 · 414 citations

Inflammation, Metabolic Syndrome, Type 1 +9

Poor Intraoperative Blood Glucose Control Is Associated with a Worsened Hospital Outcome after Cardiac Surgery in Diabetic Patients

Alexandre Ouattara, Patrick Lecomte, Yannick Le Manach et al. · Anesthesiology · 2005 · 384 citations · Full text

Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact

Agnès Hartemann–Heurtier, J. Robert, Sophie Jacqueminet et al. · Diabetic Medicine · 2004 · 222 citations